Cairo – Mubasher: The Egyptian Exchange’s (EGX) listing committee approved on Wednesday share flotation for Egysacom and DBK Pharmaceutical.
The committee amended Egysacom’s articles of incorporation.
DBK board earlier nodded to a private placement for 37.29 million shares, or 25% of capital, as well as an initial public offering of 14,928,915 shares representing 10% of capital.
